- Home
- ZVSA vs SGBX Comparison
ZVSA vs SGBX Comparison
Compare ZVSA & SGBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZVSA
- SGBX
- Stock Information
- Founded
- ZVSA 2014
- SGBX 2007
- Country
- ZVSA United States
- SGBX United States
- Employees
- ZVSA N/A
- SGBX N/A
- Industry
- ZVSA Biotechnology: Pharmaceutical Preparations
- SGBX RETAIL: Building Materials
- Sector
- ZVSA Health Care
- SGBX Consumer Discretionary
- Exchange
- ZVSA Nasdaq
- SGBX Nasdaq
- Market Cap
- ZVSA 2.3M
- SGBX 2.1M
- IPO Year
- ZVSA N/A
- SGBX 2017
- Fundamental
- Price
- ZVSA $1.08
- SGBX $0.60
- Analyst Decision
- ZVSA Strong Buy
- SGBX
- Analyst Count
- ZVSA 1
- SGBX 0
- Target Price
- ZVSA $240.00
- SGBX N/A
- AVG Volume (30 Days)
- ZVSA 3.6M
- SGBX 3.9M
- Earning Date
- ZVSA 11-14-2024
- SGBX 11-26-2024
- Dividend Yield
- ZVSA N/A
- SGBX N/A
- EPS Growth
- ZVSA N/A
- SGBX N/A
- EPS
- ZVSA N/A
- SGBX N/A
- Revenue
- ZVSA N/A
- SGBX $8,193,436.00
- Revenue This Year
- ZVSA N/A
- SGBX $273.79
- Revenue Next Year
- ZVSA N/A
- SGBX $39.31
- P/E Ratio
- ZVSA N/A
- SGBX N/A
- Revenue Growth
- ZVSA N/A
- SGBX N/A
- 52 Week Low
- ZVSA $1.05
- SGBX $0.50
- 52 Week High
- ZVSA $42.35
- SGBX $20.20
- Technical
- Relative Strength Index (RSI)
- ZVSA 27.91
- SGBX 31.30
- Support Level
- ZVSA $1.34
- SGBX $0.50
- Resistance Level
- ZVSA $1.89
- SGBX $0.76
- Average True Range (ATR)
- ZVSA 0.25
- SGBX 0.17
- MACD
- ZVSA -0.08
- SGBX -0.04
- Stochastic Oscillator
- ZVSA 1.29
- SGBX 8.95
About ZVSA ZyVersa Therapeutics Inc.
ZyVersa Therapeutics Inc is a clinical-stage biopharmaceutical company leveraging proprietary technologies to develop drugs for patients with chronic renal or inflammatory diseases with high unmet medical needs. The company has two proprietary globally licensed drug development platforms which are Cholesterol Efflux MediatorTM, VAR 200 (2-hydroxypropyl-beta-cyclodextrin) is an injectable drug in clinical development for the treatment of renal diseases. and IC 100 is a monoclonal antibody inflammasome ASC inhibitor in preclinical development for the treatment of inflammatory conditions.
About SGBX Safe & Green Holdings Corp.
Safe & Green Holdings Corp is a modular solutions company. The company currently provides modules made out of both code-engineered cargo shipping containers and wood for use as both permanent or temporary structures for residential housing use and commercial use, including for health care facilities. It operates in four segments: construction services; medical; real estate development; and environmental. The company generates the majority of its revenue from the Construction segment includes the company's manufacturing unit SG ECHO and other modules projects.